Point-of-Care Testing News
-
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries. Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including ...
-
Medical Equipment Pump Solutions
Medical Equipment Pump Solutions Industry Overview IVD, which stands for in vitro diagnostics, refers to products that conduct testing on samples taken from the human body (such as blood, body fluids, and tissues) outside of the body in order to obtain clinical diagnostic information. The IVD industry is subdivided into various sectors including immunodiagnostics, clinical chemistry, molecular ...
-
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has recently announced a series of new Anti-Small Molecule Label Antibodies to facilitate the development of nucleic acid lateral flow immunoassay (NALFIA). These antibodies can specifically bind to small molecule labels and offer customers multiple choices, including Anti Digoxin monoclonal ...
-
Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test
Today, the Baker-Polito Administration announced that more than $1.5 million has been awarded to four projects that seek to increase testing capacity and provide solutions for coronavirus testing. The funding is through the Accelerating Coronavirus Testing Solutions (A.C.T.S.) Program, designed and administered by the Massachusetts Life Sciences Center, which supports projects focused on two core ...
-
Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development Efforts
Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced today that the Company has entered a definitive agreement to acquire 100% of the share capital of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics (“LightDeck”), a pioneer in innovative planar waveguide ...
-
HiberGene Diagnostics introduces brand new UK division at NEQAS event
HiberGene Diagnostics, the leading manufacturer of molecular diagnostics products in Ireland, is pleased to announce that it will supply its innovative point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland. These high-quality testing solutions cover infectious and transmissible disease areas – including respiratory, sexually ...
-
New Product Launch For EKF Diagnostics
EKF Diagnostics Holdings has launched its latest product as it looks to identify new opportunities. EKF Link is a digital connectivity service for the secure management of point-of-care (POC) analysers and associated data on one platform. It is designed to enable the real-time remote management of data, such as patient test results, quality control, calibration results, operator ...
By MediWales
-
Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results
The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border. CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit. Chiricahua Community Health Centers, Inc. (CCHCI) today announced a collaboration ...
-
Major clinical study shows Virusight’s SpectraLIT instantly detects COVID-19 with 96.3% accuracy
Virusight Diagnostic, a world leader in combining artificial intelligence software and spectral technology today announced the results of a major clinical study that found its ultra-rapid, point of care Pathogens Diagnostic solution consistently delivers 96.3% accuracy when compared to the gold standard RT-PCR. The study was conducted by the Department of Science and Technology, University of ...
By Virusight
-
SQI Diagnostics - Lung Health Diagnostic Testing
Eric Brouwer, Ph.D., Chief Scientific Officer at SQI Diagnostics, a company focused on the science of lung health, discusses the development and manufacture of respiratory health and precision medicine tests. Their tests simplify and improve COVID-19 mobile PCR, Point of Care antigen testing and antibody monitoring, Rapid Acute Lung Injury testing, donor organ transplant informatics, and ...
-
Anavasi Diagnostics Announces FDA EUA Submission for Its COVID-19 Test
Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). Anavasi is a medical technology company focused on the development of novel molecular diagnostic testing. It uses a ...
-
How portable diagnostic readers are changing the future for patient care
There are numerous ways to provide quality diagnosis and preventative care. One of them is by investing in portable scanners, adopting huge benefits for improved healthcare procedures. What is a portable diagnostic reader? Usually a handheld device, measuring health parameters and helping to diagnose a patient using smart algorithms from a chosen assay. At AgPlus, The Agilis Reader works in ...
-
LightDeck Diagnostics Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. This year’s list honors businesses that are making the biggest impact on their industries and culture as a whole—ultimately thriving in ...
-
LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Department of Defense (DoD). The funds will be used to develop a rapid, quantitative, multiplexed test for ...
-
Quidel Announces Preliminary Revenue for Fourth Quarter 2021
Quidel Corporation (NASDAQ: QDEL) (“Quidel”),a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects total revenues in the fourth quarter of 2021 to be in the range of $633 million to $637 million and full year total revenues to be in the range of $1,695 million to $1,699 million. COVID-19 ...
-
TearLab Corporation Announces Adam Szaronos as President and Chief Executive Officer, and Jim Mazzo as Executive Chairman of the Board
TearLab Corporation, a global ophthalmic diagnostics company marketing point-of-care laboratory testing, today announced that Adam Szaronos has been appointed President and Chief Executive Officer by the company's Board of Directors, effective immediately. Mr. Szaronos has been instrumental in leading teams and bringing innovations to market to address unmet needs throughout eye care. Mr. ...
By SOFIE
-
EIB backs Belgian rapid COVID-19 PCR Test developer miDiagnostics
miDiagnostics has been granted a €20 million loan from European Investment Bank to scale up its research and development activities and accelerate the market launch of its diagnostics solution. With EU backing, the EIB financing will strengthen home-grown European technology that can play an important role in helping to bring the pandemic under control. The transaction is supported by ...
-
Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association
Visby Medical™, a leading medical diagnostic company, today announced results from the cross-sectional single visit patient outcomes and implementation study, which evaluated self-collected vaginal swab samples from 55 women using the Visby Medical Sexual Health Click Test for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). The results of this ...
-
New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability
Anavasi Diagnostics, a medical technology company focused on the development of novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology, today announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative. The funding will accelerate the launch and broad market ...
-
CEO Nick Traggis is working to scale manufacturing as the healthcare market demands faster point-of-care diagnostics.
Traggis started working with LightDeck Diagnostics founder Chris Myatt at a previous endeavor, Precision Photonics, a Boulder-based manufacturer of laser optics, in the early 2000s. Originally named MBio Diagnostics, LightDeck began as a “skunkworks effort” inside Precision. “I ended up taking over the reins there at Precision Photonics around the time Chris started focusing ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you